本頁面由Tiger Trade Technology Pte. Ltd.提供服務

X4製藥

3.50
+0.10002.94%
盤後3.500.00000.00%19:30 EDT
成交量:125.29萬
成交額:433.27萬
市值:3.47億
市盈率:-3.95
高:3.55
開:3.44
低:3.24
收:3.40
52周最高:4.83
52周最低:2.80
股本:9,914.67萬
流通股本:6,235.43萬
量比:0.91
換手率:2.01%
股息:- -
股息率:- -
每股收益(TTM):-0.8867
每股收益(LYR):-1.8726
淨資產收益率:-113.08%
總資產收益率:-28.15%
市淨率:2.23
市盈率(LYR):-1.87

資料載入中...

2022/06/07

重要事件披露

8-K - Current report
2022/05/20

重要事件披露

8-K - Current report
2022/05/12

SEC問詢函

CORRESP [Cover] - Correspondence
2022/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/12

重要事件披露

8-K - Current report
2022/03/17

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/17

重要事件披露

8-K - Current report
2022/03/10

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/03

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

重要事件披露

8-K - Current report
2022/01/26

重要事件披露

8-K/A [Amend] - Current report
2022/01/25

重要事件披露

8-K - Current report
2022/01/19

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals